Oyekan A[au] - Search Results

Year	Number of Results
1984	4
1986	2
1987	2
1988	3
1989	1
1990	3
1991	5
1993	3
1994	3
1995	2
1997	1
1998	3
1999	2
2000	3
2001	4
2002	5
2003	10
2004	4
2005	3
2006	5
2007	4
2008	2
2009	2
2010	4
2011	1
2012	2
2013	4
2014	1
2015	1
2016	2
2018	2
2019	1
2020	1
2021	1
2022	3

1

Obstructive sleep apnea in patients with Down syndrome: current perspectives.

Simpson R, Oyekan AA, Ehsan Z, Ingram DG. Simpson R, et al. Among authors: oyekan aa. Nat Sci Sleep. 2018 Sep 13;10:287-293. doi: 10.2147/NSS.S154723. eCollection 2018. Nat Sci Sleep. 2018. PMID: 30254502 Free PMC article. Review.

2

PPARs and their effects on the cardiovascular system.

Oyekan A. Oyekan A. Clin Exp Hypertens. 2011;33(5):287-93. doi: 10.3109/10641963.2010.531845. Epub 2011 Jul 1. Clin Exp Hypertens. 2011. PMID: 21721973 Review.

3

Interaction of oxidative stress, nitric oxide and peroxisome proliferator activated receptor gamma in acute renal failure.

Yousefipour Z, Oyekan A, Newaz M. Yousefipour Z, et al. Among authors: oyekan a. Pharmacol Ther. 2010 Mar;125(3):436-45. doi: 10.1016/j.pharmthera.2009.12.004. Epub 2010 Feb 1. Pharmacol Ther. 2010. PMID: 20117134 Review.

4

Fumarate exerted an antihypertensive effect and reduced kidney injury molecule (KIM)-1 expression in deoxycorticosterone acetate-salt hypertension.

Edosuyi O, Choi M, Igbe I, Oyekan A. Edosuyi O, et al. Among authors: oyekan a. Clin Exp Hypertens. 2021 Aug 18;43(6):555-564. doi: 10.1080/10641963.2021.1916943. Epub 2021 Apr 21. Clin Exp Hypertens. 2021. PMID: 33879002

5

Regulation of hypoxia inducible factor/prolyl hydroxylase binding domain proteins 1 by PPARα and high salt diet.

Ozurumba E, Mathew O, Ranganna K, Choi M, Oyekan A. Ozurumba E, et al. Among authors: oyekan a. J Basic Clin Physiol Pharmacol. 2018 Mar 28;29(2):165-173. doi: 10.1515/jbcpp-2017-0074. J Basic Clin Physiol Pharmacol. 2018. PMID: 29500923

6

Distribution of Breast Cancer Subtypes Among Nigerian Women and Correlation to the Risk Factors and Clinicopathological Characteristics.

Adeniji AA, Dawodu OO, Habeebu MY, Oyekan AO, Bashir MA, Martin MG, Keshinro SO, Fagbenro GT. Adeniji AA, et al. Among authors: oyekan ao. World J Oncol. 2020 Aug;11(4):165-172. doi: 10.14740/wjon1303. Epub 2020 Aug 10. World J Oncol. 2020. PMID: 32849957 Free PMC article.

7

Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging.

Long DA, Newaz MA, Prabhakar SS, Price KL, Truong LD, Feng L, Mu W, Oyekan AO, Johnson RJ. Long DA, et al. Among authors: oyekan ao. Kidney Int. 2005 Nov;68(5):2154-63. doi: 10.1111/j.1523-1755.2005.00671.x. Kidney Int. 2005. PMID: 16221214 Free article.

8

Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure.

Yousefipour Z, Hercule H, Truong L, Oyekan A, Newaz M. Yousefipour Z, et al. Among authors: oyekan a. J Pharmacol Exp Ther. 2007 Aug;322(2):461-8. doi: 10.1124/jpet.107.122473. Epub 2007 May 9. J Pharmacol Exp Ther. 2007. PMID: 17494862

9

Interaction between frusemide and aspirin.

Oyekan AO, Laniyonu AA, Ashorobi RB. Oyekan AO, et al. Gen Pharmacol. 1984;15(2):163-6. doi: 10.1016/0306-3623(84)90102-2. Gen Pharmacol. 1984. PMID: 6714643

10

Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat.

Blanton A, Nsaif R, Hercule H, Oyekan A. Blanton A, et al. Among authors: oyekan a. J Hypertens. 2006 Sep;24(9):1865-72. doi: 10.1097/01.hjh.0000242412.88653.f2. J Hypertens. 2006. PMID: 16915037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results